Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Smoking Cessation App. in Arabic

Study ID: NCT06766227
Start Date: 2025-06-01
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

iEndSmokin App

Educational Session

Sponsor

Yarmouk University

Source: clinicaltrials.gov

Share:
Add to list

Complicated Rhinosinusitis

Study ID: NCT06606873
Start Date: 2025-07-01
End Date: 2027-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach

Study ID: NCT04344873
Start Date: 2025-09-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Placebo

Abatacept 10 mg/kg

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy

Study ID: NCT06819176
Start Date: 2025-04-23
End Date: 2029-01-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Lenkavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

HILT Dose Optimization for Knee Osteoarthritis Pain

Study ID: NCT06916676
Start Date: 2025-04-23
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Low-Dose High-Intensity Laser Therapy (10 J/cm²)

Medium-Dose High-Intensity Laser Therapy (15 J/cm²)

High-Dose High-Intensity Laser Therapy (20 J/cm²)

Sham High-Intensity Laser Therapy

Sponsor

Al Hayah University in Cairo

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration

Study ID: NCT06470373
Start Date: 2025-07
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

434

Intervention / Treatment

RBS-001 Solution for intravitreal injection

Eylea® Solution for intravitreal injection

Sponsor

Rophibio, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

Study ID: NCT06630273
Start Date: 2025-04-30
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment
Sponsor

Canadian Cancer Trials Group

Source: clinicaltrials.gov

Share:
Add to list

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

Study ID: NCT06902376
Start Date: 2025-06
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Cemiplimab

XL092

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

NHLBI-Emory Advanced Cardiac CT Reconstruction

Study ID: NCT05372627
Start Date: 2025-04-23
End Date: 2031-01-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Source: clinicaltrials.gov

Share:
Add to list

Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization

Study ID: NCT06925776
Start Date: 2025-05-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

106

Intervention / Treatment

CHOOSE Home Intervention

Usual Care

Sponsor

Montefiore Medical Center

Source: clinicaltrials.gov

Share:
Add to list